Evidence map›Paper›PMID 38686221›Full record

ReviewCureus2024

''Myth Busting in Infectious Diseases'': A Comprehensive Review.

Ali Almajid, Shatha Almuyidi, Shatha Alahmadi, Sarah Bohaligah, Layal Alfaqih, Abdulelah Alotaibi, Albatul Almarzooq, Asmaa Alsarihi, Zaina Alrawi, Rahaf Althaqfan and 3 more

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ali AlmajidInternal Medicine, King Fahad Specialist Hospital, Dammam, SAU.
Shatha AlmuyidiMedicine, Umm Al-Qura University, Makkah, SAU.
Shatha AlahmadiMedicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
Sarah BohaligahMedicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
Layal AlfaqihMedicine, Taif University, Taif, SAU.
Abdulelah AlotaibiMedicine, Taif University, Taif, SAU.
Albatul AlmarzooqMedicine, Vision College, Riyadh, SAU.
Asmaa AlsarihiApplied Medical Sciences, Taibah University, AlMadinah, SAU.
Zaina AlrawiMedicine, King Abdulaziz University, Jeddah, SAU.
Rahaf AlthaqfanApplied Medical Sciences, King Khalid University, Khamis Mushait, SAU.
Rahma AlamoudiMedicine, Ibn Sina National College for Medical Studies, Jeddah, SAU.
Sultan AlbaqamiInternal Medicine, Al Noor Specialist Hospital, Makkah, SAU.
Alaa H AlaliInfectious Diseases, King Saud Medical City, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics have played a pivotal role in modern medicine, drastically reducing mortality rates associated with bacterial infections. Despite their significant contributions, the emergence of antibiotic resistance has become a formidable challenge, necessitating a re-evaluation of antibiotic use practices. The widespread belief in clinical practice that bactericidal antibiotics are inherently superior to bacteriostatic ones lacks consistent support from evidence in randomized controlled trials (RCTs). With the latest evidence, certain infections have demonstrated equal or even superior efficacy with bacteriostatic agents. Furthermore, within clinical practice, there is a tendency to indiscriminately order urine cultures for febrile patients, even in cases where alternative etiologies might be present. Consequently, upon obtaining a positive urine culture result, patients often receive antimicrobial prescriptions despite the absence of clinical indications warranting such treatment. Furthermore, it is a prevailing notion among physicians that extended durations of antibiotic therapy confer potential benefits and mitigate the emergence of antimicrobial resistance. Contrary to this belief, empirical evidence refutes such assertions. This article aims to address common myths and misconceptions within the field of infectious diseases.

Indexed as

adverse effectsantibiotic resistanceantibioticscefazolinmisconceptionsmythsstreptococcus pyogenestrimethoprim-sulfamethoxazoleurinary tract infections

Identifiers

PMID38686221
PMCPMC11056812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.